WNK2 and primary cutaneous T-cell non-Hodgkin lymphoma: We have identified one important signaling molecule, the mitogen-activated protein kinase p38γ, which is overexpressed in CTCL cells, but not in normal healthy T cells [5]; this makes it a good target for developing a drug against CTCL.